Delivering anti-cancer drugs beyond the blood-brain barrier

Project Information

DOMEUS

Grant agreement ID: 960141

DOI 10.3030/960141

Project closed

EC signature date 15 October 2020

Start date 1 October 2020

End date 30 September 2022

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 2 995 353,50

EU contribution € 2 064 325,00

Coordinated by

CARTHERA
France

Deliverables

Documents, reports (1)

Clinical Trial Authorization

Public document showing authorization for Cathera's pivotal trial in the DOMEUS project.

Publications

Peer reviewed articles (1)

Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma

Author(s): Ahmed Idbaih, Michael Canney, Lisa Belin, Carole Desseaux, Alexandre Vignot, Guillaume Bouchoux, Nicolas Asquier, Bruno Law-Ye, Delphine Leclercq, Anne Bissery, Yann De Rycke, Clementine Trosch, Laurent Capelle, Marc Sanson, Khe Hoang-Xuan, Caroline Dehais, Caroline Houillier, Florence Laigle-Donadey, Bertrand Mathon, Arthur André, Cyril Lafon, Jean-Yves Chapelon, Jean-Yves Delattre, Alexandre Ca
Published in: Clinical Cancer Research, Issue 25/13, 2019, Page(s) 3793-3801, ISSN 1078-0432
Publisher: American Association for Cancer Research
DOI: 10.1158/1078-0432.ccr-18-3643